These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14981088)

  • 21. Interaction of a peptide derived from the N-heptad repeat region of gp41 Env ectodomain with model membranes. Modulation of phospholipid phase behavior.
    Pascual R; Contreras M; Fedorov A; Prieto M; Villalaín J
    Biochemistry; 2005 Nov; 44(43):14275-88. PubMed ID: 16245944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fully hydrophobic HIV gp41 adopts a hemifusion-like conformation in phospholipid bilayers.
    Lee M; Morgan CA; Hong M
    J Biol Chem; 2019 Oct; 294(40):14732-14744. PubMed ID: 31409642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of a putative gp41 dimerization domain in human immunodeficiency virus type 1 membrane fusion.
    Liu J; Deng Y; Li Q; Dey AK; Moore JP; Lu M
    J Virol; 2010 Jan; 84(1):201-9. PubMed ID: 19846514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
    Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
    Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion.
    Wang S; York J; Shu W; Stoller MO; Nunberg JH; Lu M
    Biochemistry; 2002 Jun; 41(23):7283-92. PubMed ID: 12044159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
    Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41.
    Gallo SA; Clore GM; Louis JM; Bewley CA; Blumenthal R
    Biochemistry; 2004 Jun; 43(25):8230-3. PubMed ID: 15209519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion.
    Sackett K; Shai Y
    Biochemistry; 2002 Apr; 41(14):4678-85. PubMed ID: 11926830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane perturbing actions of HIV type 1 glycoprotein 41 domains are inhibited by helical C-peptides.
    Mobley PW; Barry JA; Waring AJ; Sherman MA; Gordon LM
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):224-42. PubMed ID: 17331029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.
    Geng X; Liu Z; Yu D; Qin B; Zhu Y; Cui S; Chong H; He Y
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31277353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entry.
    Wang X; Xiong W; Ma X; Wei M; Chen Y; Lu L; Debnath AK; Jiang S; Pan C
    PLoS One; 2012; 7(9):e44874. PubMed ID: 22970321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.
    Jiang S; Debnath AK
    Biochem Biophys Res Commun; 2000 Apr; 270(1):153-7. PubMed ID: 10733920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The fusion activity of HIV-1 gp41 depends on interhelical interactions.
    Suntoke TR; Chan DC
    J Biol Chem; 2005 May; 280(20):19852-7. PubMed ID: 15772068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
    Pereira FB; Goñi FM; Muga A; Nieva JL
    Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fusion peptide domain is the primary membrane-inserted region and enhances membrane interaction of the ectodomain of HIV-1 gp41.
    Cheng SF; Chien MP; Lin CH; Chang CC; Lin CH; Liu YT; Chang DK
    Mol Membr Biol; 2010 Jan; 27(1):31-44. PubMed ID: 19995328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: implications for membrane fusion.
    Liu J; Shu W; Fagan MB; Nunberg JH; Lu M
    Biochemistry; 2001 Mar; 40(9):2797-807. PubMed ID: 11258890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide and non-peptide HIV fusion inhibitors.
    Jiang S; Zhao Q; Debnath AK
    Curr Pharm Des; 2002; 8(8):563-80. PubMed ID: 11945159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.